APA (7th ed.) Citation

Danese, S., Subramaniam, K., Van Zyl, J., Adsul, S., Lindner, D., Roth, J., & Vermeire, S. (2021). Vedolizumab treatment persistence and safety in a 2‐year data analysis of an extended access programme. Alimentary Pharmacology & Therapeutics, 53(2), 265. https://doi.org/10.1111/apt.16160

Chicago Style (17th ed.) Citation

Danese, Silvio, Kavitha Subramaniam, Jan Van Zyl, Shashi Adsul, Dirk Lindner, Jeannine Roth, and Séverine Vermeire. "Vedolizumab Treatment Persistence and Safety in a 2‐year Data Analysis of an Extended Access Programme." Alimentary Pharmacology & Therapeutics 53, no. 2 (2021): 265. https://doi.org/10.1111/apt.16160.

MLA (9th ed.) Citation

Danese, Silvio, et al. "Vedolizumab Treatment Persistence and Safety in a 2‐year Data Analysis of an Extended Access Programme." Alimentary Pharmacology & Therapeutics, vol. 53, no. 2, 2021, p. 265, https://doi.org/10.1111/apt.16160.